Rebecca Fitzgerald
#74,695
Most Influential Person Now
Scientist
Rebecca Fitzgerald's AcademicInfluence.com Rankings
Rebecca Fitzgeraldphilosophy Degrees
Philosophy
#5901
World Rank
#8831
Historical Rank
Logic
#3763
World Rank
#4968
Historical Rank
Download Badge
Philosophy
Rebecca Fitzgerald's Degrees
- Bachelors Biology University of Oxford
Similar Degrees You Can Earn
Why Is Rebecca Fitzgerald Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rebecca Clare Fitzgerald is a British medical researcher whose work focuses on the early detection and treatment of oesophageal cancers. She is a tenured Professor of Cancer Prevention and Program Leader at the Medical Research Council Cancer Unit of the University of Cambridge. In addition to her professorship, Fitzgerald is currently the Director of Medical Studies for Trinity College, Cambridge, where she is also a Fellow. She is also an Honorary Consultant in Gastroenterology and General Medicine at Cambridge's Addenbrooke's Hospital. She is also the co-leader of the CRUK Cambridge Institute Early Detection Programme.
Rebecca Fitzgerald's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus (2013) (1115)
- Somatic mutant clones colonize the human esophagus with age (2018) (670)
- Toward understanding and exploiting tumor heterogeneity (2015) (557)
- Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research (2010) (524)
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers (2015) (461)
- Oesophageal cancer (2017) (388)
- The landscape of somatic mutation in normal colorectal epithelial cells (2018) (378)
- Patterns of somatic structural variation in human cancer genomes (2020) (377)
- Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. (1999) (370)
- Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. (1996) (326)
- Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study (2010) (311)
- Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis (2014) (306)
- Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance (2016) (283)
- Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. (2010) (270)
- scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation (2019) (255)
- Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants (2002) (253)
- Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma (2015) (236)
- Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus (2012) (234)
- Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study (2015) (216)
- Germline CDH1 deletions in hereditary diffuse gastric cancer families (2009) (202)
- Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
- History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. (2010) (194)
- Inflammatory gradient in Barrett’s oesophagus: implications for disease complications (2002) (187)
- Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (2020) (180)
- A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus (2013) (179)
- Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics (2018) (169)
- Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus. (2011) (163)
- Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. (2013) (161)
- Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers (2010) (159)
- Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. (2005) (149)
- Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma (2006) (148)
- Hereditary diffuse gastric cancer: updated clinical practice guidelines. (2020) (145)
- A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. (2010) (144)
- Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett’s oesophagus (2005) (143)
- Screening for oesophageal cancer (2012) (140)
- Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. (2017) (138)
- The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic (2018) (135)
- Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer (2008) (133)
- Rigorous Surveillance Protocol Increases Detection of Curable Cancers Associated with Barrett's Esophagus (2001) (129)
- International cancer seminars: a focus on esophageal squamous cell carcinoma (2017) (126)
- Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. (2015) (124)
- Precision prevention of oesophageal adenocarcinoma (2015) (124)
- Non-endoscopic screening biomarkers for Barrett’s oesophagus: from microarray analysis to the clinic (2009) (120)
- Early diagnosis of oesophageal cancer (2009) (119)
- Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis (2016) (115)
- Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. (2012) (113)
- In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. (2006) (112)
- Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk (2008) (112)
- A review of the current understanding and clinical utility of miRNAs in esophageal cancer. (2013) (109)
- Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. (2007) (107)
- Gastrin-Induced Cyclooxygenase-2 Expression in Barrett’s Carcinogenesis (2004) (102)
- The mutational landscape of human somatic and germline cells (2020) (101)
- Clinical implications of E-cadherin associated hereditary diffuse gastric cancer (2004) (101)
- A Deep Learning Framework for Predicting Response to Therapy in Cancer. (2019) (99)
- Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus. (2003) (99)
- Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus (2015) (93)
- A non-endoscopic device to sample the oesophageal microbiota: a case-control study (2016) (90)
- Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial (2020) (89)
- Recent Developments in the Molecular Characterization of Barrett’s Esophagus (1998) (87)
- Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. (2017) (87)
- Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. (2015) (82)
- Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma (2017) (81)
- Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance (2006) (81)
- Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study (2018) (78)
- A clinically translatable hyperspectral endoscopy (HySE) system for imaging the gastrointestinal tract (2019) (76)
- Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia (2017) (75)
- Facilitating a culture of responsible and effective sharing of cancer genome data (2016) (75)
- Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. (2013) (74)
- Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. (2014) (73)
- High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome. (2019) (73)
- Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status (2017) (72)
- Impaired transforming growth factor β signalling in Barrett’s carcinogenesis due to frequent SMAD4 inactivation (2005) (71)
- Barrett’s oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? (2005) (71)
- Early detection of cancer (2022) (70)
- DNA Methylation as an Adjunct to Histopathology to Detect Prevalent, Inconspicuous Dysplasia and Early-Stage Neoplasia in Barrett's Esophagus (2012) (70)
- Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. (1997) (70)
- Retinoic acid-induced glandular differentiation of the oesophagus (2006) (69)
- Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma (2011) (69)
- Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus. (1998) (67)
- Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. (2010) (65)
- The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma. (2017) (65)
- Genetic predisposition to gastro-oesophageal cancer. (2010) (63)
- Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens (2017) (62)
- Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells. (2005) (61)
- Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus (2012) (60)
- Screening for Barrett's Esophagus. (2015) (59)
- Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study (2017) (58)
- Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining. (2019) (58)
- Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. (2017) (56)
- Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients (2019) (55)
- Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure (2020) (55)
- Barrett’s oesophagus, dysplasia and pharmacologic acid suppression (2001) (55)
- The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus (2014) (54)
- Extensive phylogenies of human development inferred from somatic mutations (2021) (52)
- Genomic copy number predicts esophageal cancer years before transformation (2020) (51)
- Familial gastric cancer - aetiology and pathogenesis. (2006) (51)
- Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. (2018) (50)
- Identification and clinical implementation of biomarkers for Barrett's esophagus. (2012) (49)
- Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data. (2020) (47)
- Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. (2021) (47)
- The Impact of Prophylactic Total Gastrectomy on Health-Related Quality of Life: A Prospective Cohort Study (2014) (46)
- Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition (2021) (46)
- Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms (2017) (45)
- Amplification of TRIM44: Pairing a Prognostic Target With Potential Therapeutic Strategy (2014) (45)
- The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation (2014) (45)
- Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma (2016) (45)
- Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence (2021) (45)
- Body Mass Index, Smoking, and Alcohol and Risks of Barrett’s Esophagus and Esophageal Adenocarcinoma: A UK Prospective Cohort Study (2014) (45)
- Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma (2018) (45)
- Treatment for Barrett's oesophagus. (2010) (44)
- Effect of Acid Suppression on Molecular Predictors for Esophageal Cancer (2006) (42)
- Sex differences in oncogenic mutational processes (2019) (41)
- Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma (2017) (40)
- Cellular origin of Barrett's metaplasia and oesophageal stem cells. (2010) (39)
- A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma (2008) (39)
- Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling. (2020) (38)
- A systematic approach to therapeutic target selection in oesophago-gastric cancer (2012) (37)
- Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux (2018) (37)
- Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran (2014) (36)
- Developing a nonendoscopic screening test for Barrett's esophagus. (2011) (36)
- Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (35)
- Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis (2013) (35)
- Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. (2016) (35)
- Barrett’s Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice (2014) (34)
- Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma (2009) (34)
- Triage-driven diagnosis of Barrett’s esophagus for early detection of esophageal adenocarcinoma using deep learning (2021) (34)
- Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and adenocarcinoma risk (2007) (34)
- Pregnancy after prophylactic total gastrectomy (2010) (33)
- Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett’s esophagus (2015) (33)
- Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett’s Esophagus (2018) (33)
- The '–omics' revolution and oesophageal adenocarcinoma (2014) (32)
- New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice? (2018) (32)
- Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis. (2004) (32)
- Gastro-Esophageal Reflux Disease Symptoms and Demographic Factors as a Pre-Screening Tool for Barrett’s Esophagus (2014) (31)
- Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma (2016) (31)
- The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC) (2017) (30)
- E-Cadherin Mutations and Hereditary Gastric Cancer: Prevention by Resection? (2002) (30)
- In Vitro Acid Exposure has a Differential Effect on Apoptotic and Proliferative Pathways in a Barrett's Adenocarcinoma Cell Line (2004) (30)
- Esophageal manifestations of rheumatic disorders. (1997) (30)
- Upright versus supine reflux in gastroesophageal reflux disease (2001) (29)
- Molecular markers for Barrett's esophagus and its progression to cancer (2013) (29)
- Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes. (2015) (29)
- Selective Loss of TGFβ Smad-Dependent Signalling Prevents Cell Cycle Arrest and Promotes Invasion in Oesophageal Adenocarcinoma Cell Lines (2007) (29)
- An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC) (2016) (29)
- Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. (2014) (28)
- Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. (2005) (27)
- Barrett's oesophagus and adenocarcinoma (2004) (26)
- Location of Lymph Node Involvement in Patients with Esophageal Adenocarcinoma Predicts Survival (2013) (26)
- Chromosomal copy number heterogeneity predicts survival rates across cancers (2021) (26)
- Machine learning to predict early recurrence after oesophageal cancer surgery (2019) (26)
- Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma (2015) (26)
- Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma (2019) (25)
- Review article: Barrett's oesophagus and associated adenocarcinoma – a UK perspective (2004) (25)
- Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma. (2010) (25)
- Faculty Opinions recommendation of ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). (2013) (25)
- Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening (2019) (24)
- Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma (2007) (24)
- A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma. (2018) (24)
- A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy (2017) (23)
- The future of early cancer detection (2022) (23)
- Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis (2015) (23)
- Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett’s Esophagus (2015) (23)
- MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium (2015) (23)
- The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma (2016) (22)
- Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
- Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis (2021) (22)
- Whole-genome sequencing of nine esophageal adenocarcinoma cell lines (2016) (22)
- Non-endoscopic immunocytological screening test for Barrett’s oesophagus (2007) (22)
- Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 (2015) (22)
- Design and validation of a near-infrared fluorescence endoscope for detection of early esophageal malignancy (2016) (21)
- Barrett’s oesophagus: an ideal model to study cancer genetics (2009) (20)
- Biomarkers in Barrett's Esophagus: Role in Diagnosis, Risk Stratification, and Prediction of Response to Therapy. (2015) (20)
- Progressive silencing of p14ARF in oesophageal adenocarcinoma (2008) (20)
- Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagus. (2014) (20)
- Role of the micro-environment in Barrett's carcinogenesis. (2010) (20)
- Detection of early neoplasia in Barrett’s esophagus using lectin-based near-infrared imaging: an ex vivo study on human tissue (2018) (20)
- Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis (2017) (19)
- Familial gastric cancer - clinical management. (2006) (19)
- Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours (2017) (19)
- Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus. (2008) (18)
- Screening and risk stratification for Barrett's esophagus: how to limit the clinical impact of the increasing incidence of esophageal adenocarcinoma. (2013) (18)
- Women in hospital medicine: career choices and opportunities. (2001) (18)
- Research advances in esophageal diseases: bench to bedside (2013) (18)
- Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device—The CytospongeTM (2019) (17)
- Pre-Invasive Disease: Pathogenesis and Clinical Management (2011) (17)
- Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction (2019) (17)
- An in vitro model for Barrett's esophagus (1997) (17)
- Genetics and prevention of oesophageal adenocarcinoma. (2005) (16)
- Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study (2020) (16)
- Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma (2019) (16)
- 1004 Radiofrequency Ablation in Barrett's Esophagus With Confirmed Low-Grade Dysplasia: Interim Results of a European Multicenter Randomized Controlled Trial (SURF) (2013) (16)
- Early detection and therapeutics (2019) (16)
- Esophageal Adenocarcinoma 1-Mediated Epithelial to Mesenchymal Transition in β Factor-Evidence for Transforming Growth In vitro and In vivo (2006) (15)
- Past, present and future of Barrett's oesophagus. (2017) (15)
- Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s Esophagus (14)
- Big data is crucial to the early detection of cancer (2020) (14)
- Treatment for Barrett's oesophagus. (2002) (14)
- Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus. (1998) (14)
- Fluorescence imaging for the detection of early neoplasia in Barrett’s esophagus: old looks or new vision? (2014) (14)
- Alternatives to Traditional Per-Oral Endoscopy for Screening. (2017) (14)
- Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma (2018) (13)
- Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus (2018) (13)
- Diagnosis and treatment of Barrett's oesophagus. (2013) (13)
- Acid, helicobacter and immunity: a new paradigm for oesophagogastric cancer (2001) (13)
- Patient symptom experience prior to a diagnosis of oesophageal or gastric cancer: a multi-methods study (2020) (13)
- Quantitative phase and polarization imaging through an optical fiber applied to detection of early esophageal tumorigenesis (2018) (13)
- Clinical puzzle: Barrett’s oesophagus (2008) (12)
- Targeting care in Barrett's oesophagus. (2014) (12)
- Cellular mechanisms of Barrett's esophagus development. (2009) (12)
- Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot (2022) (12)
- Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach. (2020) (12)
- Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus (2021) (12)
- Acid modulation of HT 29 cell growth and differentiation An in vitro model for Barrett ’ s esophagus (1997) (12)
- Evolution and progression of Barrett’s oesophagus to oesophageal cancer (2021) (12)
- No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. (2019) (12)
- Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting (2020) (11)
- Comparative genomic hybridization of esophageal adenocarinoma and squamous cell carcinoma cell lines. (2006) (11)
- An Overview of Helicobacter pylori Infection. (2021) (11)
- The use of molecular markers in predicting dysplasia and guiding treatment. (2015) (11)
- The pathogenesis of Barrett's esophagus. (2003) (11)
- Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic (2020) (11)
- Biomarkers for Dysplastic Barrett’s: Ready for Prime Time? (2015) (11)
- The influence of symptom type and duration on the fate of the metaplastic columnar‐lined Barrett’s oesophagus (2009) (11)
- Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2016) (10)
- Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction (2022) (10)
- Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma (2021) (10)
- Esophageal Diseases. (2018) (10)
- Comparative genomic hybridization of esophageal adenocarcinoma and squamous cell carcinoma cell lines. (2006) (10)
- Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma (2017) (10)
- Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus (2017) (10)
- Hereditary Diffuse Gastric Cancer: Approaches to Screening, Surveillance, and Treatment. (2020) (9)
- Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett’s Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium (2015) (9)
- Testosterone Concentrations in Men on Chronic Glucocorticosteroid Therapy (1997) (8)
- Ablative mucosectomy is the procedure of choice to prevent Barrett’s cancer (2003) (8)
- Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. (2020) (8)
- Lung, spleen and oesophagus tissue remains stable for scRNAseq in cold preservation (2019) (8)
- Evolutionary dynamics in pre-invasive neoplasia. (2017) (8)
- High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations (2017) (8)
- Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. (2019) (8)
- Combining simple patient-oriented tests with state-of-the-art molecular diagnostics for early diagnosis of cancer (2015) (8)
- 640 Epigenetically Regulated Hoxb Cluster Genes Have a Functional Role in Barrett's Esophagus Development (2012) (7)
- Genomic instability signals offer diagnostic possibility in early cancer detection. (2021) (7)
- The risk of neoplasia in patients with barrett's esophagus indefinite for dysplasia: a multicenter cohort study. (2021) (7)
- Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies (2019) (7)
- Genomics of Esophageal Cancer and Biomarkers for Early Detection. (2016) (7)
- Where is the truth when it comes to cancer risk in Barrett's esophagus? (2012) (7)
- Barrett's oesophagus and oesophageal adenocarcinoma. (2011) (7)
- The pathogenesis of Barrett’s esophagus: A process in Continuum or discontinuum (2000) (7)
- 54 Evaluation of a Minimally-Invasive Cytosponge Esophageal Cell Collection System in Patients With Barrett's Esophagus (2015) (7)
- Serial Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Esophageal Adenocarcinoma Patients Following Resection (2021) (7)
- Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance (2017) (6)
- Let's not jump to conclusions regarding low-grade dysplasia in Barrett's esophagus. (2012) (6)
- Multi-omic cross-sectional cohort study of pre-malignant Barrett’s esophagus reveals early structural variation and retrotransposon activity (2022) (6)
- Patient-specific detection of cancer genes reveals recurrently perturbed processes in esophageal adenocarcinoma (2018) (6)
- Dissecting out the genetic origins of Barrett’s oesophagus (2008) (6)
- Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (2020) (6)
- 958 Time: A Prospective Study Combining Endoscopic Trimodal Imaging and Molecular Endpoints to Improve Risk Stratification in Barrett's Esophagus (2012) (6)
- Genomic copy number predicts esophageal cancer years before transformation (2020) (6)
- Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible? (2018) (6)
- The combination of auto fl uorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett ’ s oesophagus (2014) (6)
- Novel adaptation of brush cytology technique for short-term primary culture of squamous and Barrett's esophageal cells. (2001) (6)
- Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research. (2014) (5)
- Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma (2020) (5)
- Limitations of Heartburn and other Societies' Criteria in Barrett's Screening for Detecting De-novo Esophageal Adenocarcinoma. (2021) (5)
- Ingested asbestos in filtered beer, in addition to occupational exposure, as a causative factor in oesophageal adenocarcinoma (2019) (5)
- Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades. (2019) (5)
- Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments (2020) (5)
- MUC16 Mutations and Prognosis in Gastric Cancer: A Little Goes a Long Way. (2018) (4)
- Caspase-4: A Therapeutic Target for Peptic Ulcer Disease (2020) (4)
- Barrett metaplasia: reassessment of treatment and follow-up (2004) (4)
- Distinct cytokine patterns in Barrett's oesophagus and associated adenocarcinoma: Evidence for a shift tewards a Th2 response (2000) (4)
- Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in CDH1 mutation carriers (2007) (4)
- Signatures of Mutational Processes and Associated Risk Factors in Esophageal Squamous Cell Carcinoma: A Geographically Independent Stratification Strategy? (2016) (4)
- IRES-Mediated Protein Translation Overcomes Suppression by the p14ARF Tumor Suppressor Protein (2017) (4)
- Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy. (2021) (4)
- Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data (2021) (4)
- Gastrin-induced hyperproliferation in Barrett's esophagus. (2003) (4)
- Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial (2020) (4)
- Association of a DNA Damage Response Deficiency (DDRD) assay and prognosis in early stage Oesophageal Adenocarcinoma (2014) (3)
- KCNQ gene family members act as both tumor suppressors and oncogenes in gastrointestinal cancers (2020) (3)
- Organ-preserving approaches in oesophageal cancer. (2018) (3)
- Testing the Utility of an Integrated Analysis of Copy Number and Transcriptomics Datasets for Inferring Gene Regulatory Relationships (2013) (3)
- Epigenetic changes wipe out protective mechanisms in Barrett’s oesophagus (2008) (3)
- 310 - Efficacy of Cytosponge Directed Food Elimination Diet in Eosinophilic Esophagitis. a Pilot Trial (2018) (3)
- Cancer development: Origins in the oesophagus (2017) (3)
- Su1088 Non-Endoscopic Diagnostic Tests for Esophageal Diseases and H. pylori Using the Cytosponge (2012) (3)
- Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas (2022) (3)
- Screening for Barrett’s Oesophagus: Are We Ready for it? (2021) (3)
- The mutREAD method detects mutational signatures from low quantities of cancer DNA (2020) (3)
- Multiparametric High-Content Cell Painting Identifies Copper Ionophores as Selective Modulators of Esophageal Cancer Phenotypes (2022) (3)
- Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial (2022) (3)
- Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations. (2017) (3)
- 540 Biomarkers for Early Detection of Esophageal Squamous Cell Dysplasia and Carcinoma (2014) (3)
- Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes (2022) (2)
- Time to Challenge Current Strategies for Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma (2019) (2)
- Deciphering the Immune Complexity in Esophageal Adenocarcinoma and Pre-Cancerous Lesions With Sequential Multiplex Immunohistochemistry and Sparse Subspace Clustering Approach (2022) (2)
- Barrett's esophagus. (2008) (2)
- Pilot Randomized Cross-over study comparing the efficacy of transnasal disposable endosheath to standard endoscopy to detect Barrett’s oesophagus (2016) (2)
- PWE-164 Utilizing Integrative Genomic Analysis and Proteomics to Decipher the Biology and Therapeutic Potential of Trim44 in Oesophageal Adenocarcinoma and Breast Cancer (2013) (2)
- Significance of Acid Exposure in Barrett's Esophagus (2003) (2)
- GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level (2022) (2)
- APOBEC mutagenesis is a common process in normal human small intestine (2023) (2)
- Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study (2021) (2)
- Whole exome sequencing study to detect germline pathogenic variants in PALB2 and other cancer-predisposing genes in CDH1 mutation negative diffuse gastric cancer families. (2018) (2)
- Dysplasia and early neoplasia in Barrett's oesophagus (2012) (2)
- A crosssectional analysis of Facebook comments to study public perception of a new diagnostic test called the Cytosponge. (2018) (2)
- International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study (2022) (2)
- Su2042 – Derivation of Oesophageal Organoids to Recapitulate the Heterogeneity of Primary Tumours and Provide a Model System for Precision Therapeutics (2019) (2)
- Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? (2019) (2)
- An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC) (2016) (2)
- UTILITY AND COST-EFFECTIVENESS OF A NON-ENDOSCOPIC APPROACH TO BARRETT'S ESOPHAGUS SURVEILLANCE AFTER ENDOSCOPIC THERAPY. (2021) (2)
- The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia (2022) (2)
- Biomarkers in Barrett's oesophagus and oesophageal adenocarcinoma. (2007) (2)
- Phase 2 and phase 3 multicentre studies demonstrate the potential for glycans as predictive biomarkers in barrett's oesophagus (2011) (2)
- Extensive phylogenies of human development reveal variable embryonic patterns (2020) (2)
- Oracular guidance on clinical management of early neoplastic Barrett's esophagus. (2012) (2)
- Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus (2022) (2)
- Surveillance and screening of Barrett's oesophagus. (2006) (2)
- Large-scale prospective study reveals novel risk factors for Barrett's oesophagus (2007) (2)
- Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress (2017) (2)
- Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. (2022) (2)
- Length of Barrett's oesophagus segment: Demographic associations and cancer risk (2003) (2)
- Pre-invasive disease (2013) (2)
- Conference report: improving outcomes for gastrointestinal cancer in the UK (2016) (2)
- A sinister black finding in the stomach (2019) (2)
- Significance of genetic abnormalities after photodynamic therapy. (2001) (2)
- Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study (2019) (2)
- Faculty of 1000 evaluation for Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. (2013) (1)
- PD-L1 expression and response to neo-adjuvant chemotherapy in esophageal adenocarcinoma. (2017) (1)
- 538 Feasibility and Performance Characteristics of a Novel Disposable Transnasal Capsule Device for Barrett's Esophagus Screening: A Prospective International Multicenter Trial (2017) (1)
- 644 Defining Cancer Risk in Barrett's Esophagus Using a 90-Gene Signature (2013) (1)
- Leadership roles for women in gastroenterology: New initiatives for the new generation of gastroenterologists (2016) (1)
- Examining the effects of BET, HDAC2, and EZH2 inhibition on esophageal adenocarcinoma (EAC) cell line proliferation. (2019) (1)
- A Prospective, Multicenter Study to Evaluate a Novel, Nonendoscopic Screening Device for Barrett's Esophagus in the Community Setting (2010) (1)
- Normalization of intraesophageal pH enhances differentiation and decreases proliferation in Barrett's esophagus (1998) (1)
- Dietary Fat Intake in the Aetiology of Barrett's Oesophagus and Oesophageal Adenocarcinoma – Data From a Prospective Cohort Study (EPIC-Norfolk) Using 7-Day Food Diary Data (2011) (1)
- Developing a nonendoscopic screening test for (2011) (1)
- Dietary fat intake in the aetiology of barrett's oesophagus and oesophageal adenocarcinoma: data from a prospective cohort study (EPIC-Norfolk) using 7-day food diary data (2011) (1)
- 634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX (2020) (1)
- 511a: Nasal or Standard Endoscopy (NOSE) for Diagnosis of Barrett's Oesophagus - Efficacy and Patient Tolerance (2010) (1)
- Development and evaluation of a non-endoscopic immunocytological screening test for Barrett??s esophagus (2006) (1)
- Molecular imaging via novel application of fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett’s oesophagus (2011) (1)
- THE ROLE OF POTASSIUM CHANNELS IN THE PATHOGENESIS OF GASTROINTESTINAL CANCERS AND THERAPEUTIC POTENTIAL (2022) (1)
- Design and validation of a near-infrared fluorescence endoscope for detection of early esophageal malignancy using a targeted imaging probe (2016) (1)
- Oesophageal and gastro-oesophageal junction tumours (2007) (1)
- ELEVATE – evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial (2022) (1)
- Su1450 The Combination of Autofluorescence Imaging and Probe-Based Confocal LASER Endomicroscopy Has an Excellent Diagnostic Accuracy for Dysplasia in Barrett's Esophagus (2013) (1)
- Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning (2022) (1)
- First-in-human pilot study of snapshot multispectral endoscopy for early detection of Barrett’s-related neoplasia (2021) (1)
- Author Correction: Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (1)
- 56 Cytosponge Evaluation of Eosinophilic Esophagitis in Comparison to Endoscopy: Accuracy, Safety and Tolerability (2014) (1)
- Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 (2019) (1)
- DNA Methylation Biomarkers for the Diagnosis of Barrett's Oesophagus. (2018) (1)
- PTU-154 Sirt2 Modulates the Inflammatory Response in Oesophageal Adenocarcinoma (2013) (1)
- Phase Ib trial of lapatinib oxaliplatin and capecitabine in early HER2-overexpressing esophagogastric cancer. (2010) (1)
- Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
- 250 Characterisation of Squamous Oesophageal Epithelium and Location of Epithelial Stem Cells (2009) (1)
- A systematic approach to therapeutic target selection in gastro-esophageal adenocarcinoma (2011) (1)
- * Image cytometry DNA ploidy abnormalities are an independent risk factor for cancer progression in non-dysplastic barrett's oesophagus and low grade dysplasia: results of the NIBR study (2011) (1)
- Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach (2021) (1)
- Chronic acid-suppressant use and risk of Oesophageal cancer: protocol for a longitudinal study using a large population based cohort (2021) (1)
- OC-017 TRIM44: from prognosis to therapy in oesophageal adenocarcinoma and breast cancer (2012) (1)
- Faculty Opinions recommendation of Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. (2013) (1)
- Significance of acid exposure in Barrett's esophagus. (2003) (1)
- Trimodal imaging to identify microscopic foci of signet ring cells in hereditary diffuse gastric cancer (2011) (1)
- Inflammation at the neo squamocolumnar junction in Barrett's oesophagus. (2000) (1)
- PTU-145 Prophylactic total gastrectomy for hereditory gastric cancer syndrome (2015) (1)
- 254 TRIM44: From Prognosis to Therapy in Esophageal Adenocarcinoma and Breast Cancer (2012) (1)
- PWE-069 Sampling Oesophageal Microbial Communities in Barrett’s Oesophagus Using Minimally Invasive and Endoscopic Methods (2016) (1)
- OC-053 Lectin-Based Near infra-red Molecular Imaging for Dysplasia Detection in Barrett’s Oesophagus: An ex-vivo Study on Human Tissue (2016) (1)
- Practical early cancer detection: distinguishing stable from unstable genomes in pre-cancerous tissues (2020) (1)
- Cambridge liquid biopsy “CALIBRATION” study: Can changes in circulating tumour DNA (ctDNA) predict durable tumour responses in patients with advanced oesophageal cancer receiving MEDI4736? (2019) (1)
- 370P Bespoke circulating tumour DNA assay for the detection of minimal residual disease in esophageal adenocarcinoma patients (2020) (1)
- Sa1196 UPTAKE AND ACCEPTANCE OF CYTOSPONGE SCREENING FOR BARRETT'S ESOPHAGUS IN THE PRIMARY CARE SETTING (2020) (1)
- OC-008 Defining the genetic landscape of oesophageal adenocarcinoma by next-generation sequencing (2012) (1)
- Low-cost and clinically applicable copy number profiling using repeat DNA (2018) (1)
- OFR-5 Surveillance and endoscopic recognition of gastric intestinal metaplasia and atrophic gastritis (2021) (0)
- Clonal Diaspora in Metastatic Esophageal Adenocarcinoma Describes a New Model of Cancer Progression (2018) (0)
- 475d A Clinically Applicable Three Gene Signature is Independently Highly Prognostic in Esophageal and Junctional Adenocarcinoma (2010) (0)
- O-OGC06 Genomic analysis of response to neoadjuvant chemotherapy in oesophageal adenocarcinoma (2021) (0)
- Landscape of innate and adaptive immunity targets in oesophagogastric adenocarcinoma (OGA). (2019) (0)
- eQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma. (2022) (0)
- Big data is crucial to the early detection of cancer (2020) (0)
- I am ambitious and family life is important to me. Are there any female oncologists who would recommend clinical oncology as an option where one can have both a career and a family? (2005) (0)
- Characterisation of intracellular ph control in barrett's esophagus: Evidence for an adaptive cellular response to gastro-esophageal reflux (2000) (0)
- Molecular imaging via novel application of fluorescent lectins permits rapid endoscopic identification of dysplasia in barrett's oesophagus (2011) (0)
- Mo1899 In Vitro Toxicity Studies of Novel Lectin Probes Which Have Potential to Allow Endoscopic Detection of Dysplasia in Barrett's Esophagus During Surveillance (2013) (0)
- P107 Surveillance in an expert Barrett’s centre associates with low disease-specific mortality in Barrett’s oesophagus patients (2022) (0)
- Incidence and progression of Barrett's oesophagus in clinical practice: A cohort analysis for planning of the Barrett's ESophagus Trial 3 (BEST3) comparing the Cytosponge-TFF3 test with usual care (2016) (0)
- MUC16Mutations and Prognosis in Gastric Cancer (2018) (0)
- Mo1856 Mutation of TP53 Creates an Opportunity for Synthetic Lethality in Esophageal Adenocarcinoma (2013) (0)
- ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS (2021) (0)
- Helicobacter pylori infection and severity of oesophageal disease in a cohort of of patients with Barrrett's oesophagus (2004) (0)
- A clinically translatable hyperspectral endoscopy (HySE) system for imaging the gastrointestinal tract (2019) (0)
- Abstract 3600: Early detection of esophageal adenocarcinoma using near-infrared lectin-based imaging (2018) (0)
- Sa1147 – Analysis of Socio-Economic Factors Affecting the Uptake of the Novel Medical Device Cytosponge (2019) (0)
- Faculty Opinions recommendation of The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial. (2013) (0)
- Faculty Opinions recommendation of Burden of gastrointestinal disease in the United States: 2012 update. (2013) (0)
- 935 The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics (2014) (0)
- A systems approach to cancer (2010) (0)
- M1936 Identification and Validation of Biomarkers for Use in Barrett's Oesophagus Screening (2008) (0)
- Sa2004 C-MYC As a Biomarker in Barrett's Esophagus (2013) (0)
- BASIC AND TRANSLATIONAL—ALIMENTARY TRACT Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus (2015) (0)
- Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people (2007) (0)
- ELEVATE – evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial (2022) (0)
- Consideration of histopathological subtypes and biopsy techniques in Barrett’s oesophagus surveillance programmes (1998) (0)
- Whole-genome sequencing analysis of structural variants in oesophageal adenocarcinoma (2017) (0)
- CLINICAL PUZZLE The clinical issues of Barrett ’ s oesophagus The population prevalence of Barrett ’ s oesophagus (0)
- Large scale meta-analysis identifies new genetic risk loci for esophageal adenocarcinoma (EA) and the first EA risk locus independent of Barrett’s esophagus (2017) (0)
- An in vitro study of the effects of cytokines on oesophageal repair following mechanical and PDT injury (2001) (0)
- Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux (2018) (0)
- Beyond acid suppressants in gastro-oesophageal reflux disease (2001) (0)
- PWE-177 The functional relevance of toll-like receptor 4 mutations in oesophageal adenocarcinoma (2015) (0)
- Sa2074 The mutational architecture of oesophageal adenocarcinoma (2013) (0)
- The Horizon of Screening for Barrett's Esophagus and Esophageal Cancer (2023) (0)
- P-OGC39 The smell of oesophageal adenocarcinoma: opportunities for tests and treatments (2021) (0)
- Confocal Endomicroscopy Diagnostic Criteria for Early Signet-Ring Cell Carcinoma in Hereditary Diffuse Gastric Cancer (2021) (0)
- Purification of Total RNA from Stomach Tissue Biopsies. (2021) (0)
- S1631 Hoxb Cluster Genes are Activated in Barrett's Carcinogenesis via Epigenetic Regulation (2010) (0)
- Sa1843 The Toll-Like Receptor Pathway Is Recurrently Mutated in Esophageal Adenocarcinoma (2014) (0)
- Measuring patient experience of Cytosponge using the Newcastle ENDOPREM (2022) (0)
- Relationship of presenting symptoms to outcome in columnar-lined oesophagus (CLO). (2004) (0)
- Acceptability of Tissue Collection by Cytosponge in U.S. Patients with Barrett's Esophagus (2017) (0)
- The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic (2019) (0)
- A NOVEL TECHNIQUE FOR DIAGNOSIS OF SIGNET RING CELL CARCINOMA Nastazja (2021) (0)
- The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic (2019) (0)
- Expression of Glucose Transporter 1 (GLUT1) is a marker for Poor Prognosis in Oesophageal Adenocarcinoma. (2015) (0)
- management of Barrett ' s oesophagus guidelines on the diagnosis and British Society of Gastroenterology (2013) (0)
- P-OGC44 Multi-omic cohort study of Barrett’s oesophagus reveals structural variation and retrotransposon activity to occur early in cancer evolution (2021) (0)
- Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma (2019) (0)
- A composite biomarker for esophageal cancer risk from automated analysis of a non-endoscopic device (2021) (0)
- I left work three years ago when I had twins. Now they are going to nursery. Could you advise me how to get back in the NHS. I finished my house job in 2003. (2007) (0)
- Nitrosative stress in the development and progression of oesophageal adenocarcinoma (2006) (0)
- Development and External Validation of a MAchine learning RisK prediction model as a pre-screening tool to diagnose Barrett’s Oesophagus (2019) (0)
- Assessing the clinical utility of circulating tumour DNA through longitudinal liquid biopsy sampling in oesophageal adenocarcinoma (2019) (0)
- High-content profiling reveals a unified model of copper ionophore dependent cell death in oesophageal adenocarcinoma (2021) (0)
- I am currently a fourth year medical student. I was hoping for some advice on the academic foundation placements. Do you know how many are available? (2007) (0)
- 960 Familial Clustering of Barrett's Esophagus and Esophageal Adenocarcinoma in the Netherlands (2012) (0)
- Assessment of conditional survival probability in resected esophageal adenocarcinoma. (2017) (0)
- Sa1852 Autofluorescence-Targeted Optical Biopsy Accurately Diagnoses Dysplasia in Barrett's Esophagus and Can Detect the Field of Molecular Change (2014) (0)
- Retinoic acid-induced glandular differentiation of the oesophagus. Commentary (2007) (0)
- Diseases of the oesophagus (2010) (0)
- Su1173 DNA Methylation is a Biomarker for Dysplasia and Early-Stage Neoplasia in Barrett's Esophagus: From Discovery to a Phase 4 Prospective Validation Study (2012) (0)
- PTU-192 Time: prospective study combining endoscopic trimodal imaging and molecular endpoints to risk stratify Barrett's oesophagus (2012) (0)
- Inferring the clonal evolution of oesophageal adenocarcinoma through whole genome sequencing (2014) (0)
- ERBB2 EXPRESSION IN OESOPHAGEAL ADENOCARCINOMA AND BARRETT’S OESOPHAGUS: DEMONSTRATING THE POTENTIAL FOR A PRE-EMPTIVE STRIKE (2009) (0)
- Helicobacter pylori Virulence Factor Genotyping. (2021) (0)
- Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection (2023) (0)
- Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus (2021) (0)
- 606 Integrated analysis of genome-wide copy number and expression changes reveals novel genes in oesophageal adenocarcinoma (2010) (0)
- 575 Generation and Validation of a Prognostic Gene Signature for Esophageal Adenocarcinoma (2009) (0)
- Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples (2022) (0)
- Sa1163 – The Risk of Prevalent and Incident Neoplasia in Patients with a Diagnosis of Barrett's Esophagus Indefinite for Dysplasia (2019) (0)
- S2038 An Improved Staging System for Esophageal Adenocarcinoma Based On the Number of Involved Lymph Nodes (2008) (0)
- The 2017 Dr Falk Pharma UK/Core Awards are open for applications (2016) (0)
- Faculty Opinions recommendation of Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. (2013) (0)
- Screening for Barrett Esophagus With a Nonendoscopic Sponge Capsule. (2015) (0)
- Mo1171: DUTCH, UK AND US PROFESSIONALS’ PERCEPTIONS OF SCREENING FOR BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA: A CONCEPT MAPPING STUDY (2022) (0)
- The mutREAD method detects mutational signatures from low quantities of cancer DNA (2020) (0)
- The definition and management of Barrett’s oesophagus: a case report, review of the literature and a suggestion for the future (2009) (0)
- Conditional survival probability in patients with resected oesophageal adenocarcinoma receiving neoadjuvant chemotherapy (2016) (0)
- Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics (2018) (0)
- OTU-16 A machine learning-based model to predict the presence of barrett’s oesophagus (2019) (0)
- Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
- A potential role for Periostin in Barrett’s carcinogenesis (2007) (0)
- A multisystem selenoprotein disorder with a thyroid signature (2010) (0)
- Research Progress in Barrett's Oesophagus 4 th National Symposium (2010) (0)
- A multicentre cohort study to redefine and validate pathological assessment of response to neoadjuvant therapy in treated oesophagogastric adenocarcinoma. (2016) (0)
- Altered retinoic acid signalling and its relationship to Cdx-2 in Barrett’s oesophagus and associated carcinogenesis (2005) (0)
- Stress protein response in human oesophageal epithelium may be influenced by the ex vivo culture technique (1998) (0)
- Faculty Opinions recommendation of Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. (2013) (0)
- Multispectral endoscopy for early detection of dysplasia in Barrett’s oesophagus (MuSE): a pilot study (Conference Presentation) (2019) (0)
- 973: SINGLE CELL RNA SEQUENCING SHOWS PROFOUND PHENOTYPIC SIMILARITY BETWEEN GASTRIC INTESTINAL METAPLASIA AND BARRETT'S ESOPHAGUS. (2022) (0)
- PWE-009 Dietary docosahexaenoic acid is inversely associated with the risk of developing oesophageal adenocarcinoma: a UK prospective study in the EPIC-Norfolk cohort, using information from 7-day food diaries (2012) (0)
- Abstract 3130: Extrachromosomal DNA in the cancerous transformation of Barrett’s esophagus (2023) (0)
- A cross-sectional analysis of Facebook comments to study public perception of a new diagnostic test called the CytospongeTM (2020) (0)
- PWE-020 Using microarray data to elucidate the molecular phenotype of a novel oncogene and identify a therapeutic strategy (2012) (0)
- 425: RUNX1 structural variants in oesophageal adenocarcinoma (2014) (0)
- Cohort study : Risk stratification of Barrett ’ s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel (2016) (0)
- Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial (2023) (0)
- Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study (2022) (0)
- Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma (2020) (0)
- T1931 Molecular Classification of Gastro-Esophageal Adenocarcinoma (2009) (0)
- P-109 CYTOFLOC: Evaluation of a non-endoscopic immunocytological device (Cytosponge™) for post-chemo-radiotherapy surveillance in patients with oesophageal cancer – a feasibility study (2021) (0)
- Single-cell RNA sequencing unifies developmental programs of Esophageal and Gastric Intestinal Metaplasia. (2023) (0)
- 568. THE PROGNOSTIC EFFECT OF PATHOLOGICAL LYMPH NODE REGRESSION AFTER NEOADJUVANT CHEMOTHERAPY FOR OESOPHAGEAL ADENOCARCINOMA – A MULTICENTRE STUDY (2022) (0)
- Abstract 2256: Novel prognostic targets identified using integrated analysis of copy number and expression data in esophageal adenocarcinoma (2011) (0)
- Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure (2020) (0)
- Title: MUC16 mutations and prognosis in gastric cancer; a little goes a long way (2018) (0)
- Economic Evaluation of Cytosponge®-Trefoil Factor 3 for Barrett's Oesophagus: A Cost-Utility Analysis (2020) (0)
- Medicine is the ultimate personalised technology (2017) (0)
- 57: Early detection biomarkers for oesophageal cancer (2014) (0)
- T1929 Lymph Node Location Improves the Prognostic Power of Esophageal Adenocarcinoma Staging (2009) (0)
- Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy. (2017) (0)
- OGC P04 Spatial sampling of Barrett's oesophagus reveals that tumour heterogeneity is not a useful predictor of progression to cancer (2022) (0)
- 57: Early detection biomarkers for oesophageal cancer (2014) (0)
- What are the realistic implications of finding a job for somebody who has been convicted of a minor charge? If it is too difficult to find a medical job, should I give up looking for jobs in the UK? (2006) (0)
- 423 Type 2 Immunity Linked to iRhom2 and Tylosis with Oesophageal Cancer (2019) (0)
- OFR-4 Cytosponge-TFF3 for the detection of premalignant stomach: a cohort study from the BEST3 trial (2021) (0)
- DNA methylation as a biomarker of progression in barrett's carcinogenesis (2011) (0)
- Development of a compact multimodal imaging system for rapid characterisation of intrinsic optical properties of freshly excised tissue (Conference Presentation) (2020) (0)
- Faculty Opinions recommendation of Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. (2013) (0)
- ADENOCARCINOMA – A MULTICENTRE (2022) (0)
- Polokinase-1 is a Therapeutic Target in Oesophageal Adenocarcinoma (2013) (0)
- The origin and prevention of Barrett's esophagus (2007) (0)
- Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. (2016) (0)
- Letters to the Editor (0)
- Tu2054 Siewert Type Does Not Reflect Cancer Biology at the Gastro-Esophageal Junction (2016) (0)
- Faculty Opinions recommendation of The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. (2013) (0)
- Location of Nodal Involvement Influences the Outcome in Patients With Oesophageal Adenocarcinoma (2011) (0)
- High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations (2017) (0)
- Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
- Sa1795 Using Expression Array Data to Elucidate the Molecular Phenotype of a Novel Oncogene and Identify a Therapeutic Strategy (2012) (0)
- The Cytosponge is a Safe and Well-Tolerated Method of Sampling Esophageal Tissue in Patients with Eosinophilic Esophagitis (2017) (0)
- Image Analysis of Esophageal Biopsies and Cytosponge Specimens Stained for Eosinophil Peroxidase Identifies Subjects with Eosinophilic Esophagitis: 938 (2019) (0)
- Tu1529 Superior Patient Preference and High Diagnostic Accuracy for the Detection of Barrett's Esophagus Using a Novel, Portable, Probe-Based TransNasal Endoscope (2015) (0)
- Development of a clinically translatable hyperspectral endoscopy (HySE) system and analysis methods for the improved diagnosis of gastrointestinal disease (Conference Presentation) (2020) (0)
- Faculty Opinions recommendation of Medium and long-term outcomes after pneumatic dilation or laparoscopic Heller myotomy for achalasia: a meta-analysis. (2013) (0)
- Process-specific somatic mutation distributions vary with three-dimensional genome structure (2018) (0)
- Ingested asbestos in filtered beer, in addition to occupational exposure, as a causative factor in oesophageal adenocarcinoma (2019) (0)
- A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization (2021) (0)
- cannot be evaluated. Such larger scale studies of the genetic and cell biological effects of PDT will enable us to develop a more scientific approach to the use of this emerging technology. (2001) (0)
- Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
- Mechanisms underlying the progression of Barrett's oesophagus (2006) (0)
- The combination of auto fl uorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett ’ s oesophagus (2014) (0)
- Importance of metaplastic subtypes and squamo-columnar cross-talk in the aetiopathogenesis of inflammatory and malignant complications in Barrett's oesophagus (2001) (0)
- Sa1643 - Feasibility of the Implementation of Cytosponge as a Triage Test for Reflux Symptoms in Primary Care: Barrett's Esophagus Screening Trial 3 (Best3) (2018) (0)
- OC-027 Defining Cancer Risk in Barrett’S Oesophagus using a 90-Gene Signature (2013) (0)
- Genomic evidence supports a clonal diaspora model for metastases of esophageal 1 adenocarcinoma 2 3 (2019) (0)
- W1949 C-MET Amplification in Oesophageal Adenocarcinoma Cell Lines Influences EGFR and Erbb2 Phosphorylation Status and May Provide Resistance to ERBB Targeted Therapies (2008) (0)
- Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. (2023) (0)
- HOXB cluster genes are novel potential regulators of Barrett's oesophagus development (2011) (0)
- Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis (2015) (0)
- Cytokines induce preferential squamous epithelial cell repair following photodynamic therapy for patients with Barrett's oesophagus: An in vitro model (2002) (0)
- Association between lifestyle factors and histology in Barrett's Oesophagus (2003) (0)
- Sa1924 Utility of a Biomarker Panel to Predict Progression to Esophageal Adenocarcinoma in Barrett's Esophagus (2014) (0)
- P62 Probe-based confocal laser endomicroscopy as a novel technique for diagnosis of signet ring cell carcinoma (2021) (0)
- The role of transforming growth factor beta and its receptors in the development and progression of Barrett's oesophagus (2000) (0)
- Genetics and Biomarkers in Barrett’s Esophagus and Esophageal Adenocarcinoma (2016) (0)
- Molecular Events That Underlie Metaplasia and Cancer in Barrett ’ s Esophagus GERD and Metaplasia (0)
- Cytosponge™ for post-chemoradiation surveillance of oesophageal cancer: a feasibility study. (2019) (0)
- Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma (2021) (0)
- Cell Cycle Deregulation in Pre-neoplasia: Case Study of Barrett’s Oesophagus (2010) (0)
- OTU-17 Methylation panel in the assessment of clinical response to the radio-frequency ablation for barrett’s oesophagus (2019) (0)
- Time course of metaplastic and dysplastic changes in columnar-lined oesophagus (CLO) and relationship to symptom onset. (2004) (0)
- Breath-based monitoring of liver metabolism using exogenous volatile organic compounds - towards improved detection (2020) (0)
- 1067 – A Machine Learning-Based Model to Predict the Presence of Barrett's Esophagus (2019) (0)
- 1080l: Potential Application of Lectins As Molecular Imaging Tools to Detect Dysplasia in Barrett's Oesophagus Endoscopically (2010) (0)
- T1877 A Pilot Feasibility Study of Screening for Barrett's Esophagus with a Novel Non-Endoscopic Capsule Sponge Device in a Primary Care Setting Device in a Primary Care Setting (2009) (0)
- Relationship of COX-2 expression to gastrin and cell differentiation status in Barrett's esophagus and associated carcinoma (2004) (0)
- Abstract 3596: A biomarker study of lapatinib in the neoadjuvant treatment of HER2 over expressing esophago-gastric adenocarcinoma (EGA) (2015) (0)
- Abstract 789: Determination of MAPK and Wnt pathway activity in esophageal cancer (2010) (0)
- 342. GENOMIC ANALYSIS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN OESOPHAGEAL ADENOCARCINOMA (2022) (0)
- Human and murine data suggest critical role for TGF-β in the aetiopathogenesis of Barrett's oesophagus (2001) (0)
- T1887 Development of Biomarkers for Non-Endoscopic Screening for Barrett's Esophagus (2009) (0)
- Molecular Targets in Metastatic Lymph Nodes in Oesophageal Cancer Predict Patient Survival (2011) (0)
- M1956 Genetic Inhibition of Telomerase in Different Esophageal Cell Types Leads to the Induction of ALT (2009) (0)
- Dual-modality imaging of immunofluorescence and imaging mass cytometry for whole slide imaging with accurate single-cell segmentation (2023) (0)
- Shallow Whole Genome Sequencing can Detect Copy Number Changes in FFPE Material in the Progression of Barrett's Esophagus (2017) (0)
- 1940P CALIBRATION: Can early changes in circulating tumour DNA (ctDNA) predict durable tumour responses in patients (pts) with advanced esophageal adenocarcinoma (EAC) receiving anti PD-L1 antibody durvalumab (D)? (2020) (0)
- Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus (2016) (0)
- Machine Classification of Methylomes in Cancer (2020) (0)
- 121MO ctDNA and prognosis in resected esophageal adenocarcinoma (EAC) (2020) (0)
- Faculty Opinions recommendation of The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. (2013) (0)
- Mo1897 GORD Symptoms and Demographic Factors As a Pre-Screening Tool for Barrett's Oesophagus (2013) (0)
- PTU-153 The Timing Of Oncogenic Events In The Evolution Of The Oesophageal Adenocarcinoma Genome And Implications For Clinical Diagnostics (2014) (0)
- Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
- Horizons in Medicine 25: advancing on all levels. (2013) (0)
- Sa1984 Lewis Biomarkers for Detection of Dysplasia in Barrett's Esophagus (2013) (0)
- University of Birmingham Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus (0)
- A non-endoscopic sampling device to sample the oesophageal microbiota : a case-control study (2016) (0)
- Corrigendum: Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study (2018) (0)
- Abstract 1189: Chromosomal aberrations reveal novel genes with prognostic significance in esophageal adenocarcinoma (2010) (0)
- Molecular biology of Barrett's esophagus and esophageal adenocarcinoma (2015) (0)
- Cancer-associated Mutations Co-locate with TRPA1 Hinge Formation in the Ankyrin Repeat Region (2020) (0)
- Triage-driven diagnosis for early detection of esophageal cancer using deep learning (2020) (0)
- O6 Ideal age to screen for Barrett’s oesophagus and oesophageal adenocarcinoma: modelling from the cytosponge-BEST3 trial (2022) (0)
- Tu1119 - Efficacy of Cytosponge to Assess for Recurrent or Residual Barrett's Esophagus Following Endoscopic Eradication Therapy (2018) (0)
- Amplification of tri M44: Pairing a Prognostic t arget With Potential t herapeutic Strategy (2014) (0)
- Amplification of tri M44: Pairing a Prognostic t arget With Potential t herapeutic Strategy (2014) (0)
- ID: 3525999 DEVELOPMENT OF CONFOCAL ENDOMICROSCOPY CRITERIA FOR EARLY SIGNET-RING CELL CARCINOMA INPATIENTS WITH HEREDITARY DIFFUSE GASTRIC CANCER SYNDROME (2021) (0)
- The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus (2020) (0)
- Towards the next-generation of cancer cell lines: Derivation of an organoid biobank (2016) (0)
- Major advances in gastroenterology and hepatology over the last 25 Years: Review of 25th UEG Week Anniversary Session (2017) (0)
- T1912 Lectin Targeting of Glycan Alterations to Detect Dysplasia in Barrett's Esophagus (2009) (0)
- Low-cost and clinically applicable copy number profiling using repeat DNA (2022) (0)
- A pragmatic, randomised, controlled trial of an offer of Cyrtosponge-TFF3 test compared with usual care to identify Barrett's oesophagus in primary care (2020) (0)
- Analysis of Structural Variants in Esophageal Adenocarcinoma Reveals Multiple Hits in Cell-Cell Communication Pathways (2017) (0)
- Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma. (2017) (0)
- A comparison of the yield from endoscopic surveillance in detecting early gastric cancer in CDH1+ve versus CDH1−ve HDGC families (2016) (0)
- Imaging , Diagnosis , Prognosis DNA Methylation as an Adjunct to Histopathology to Detect Prevalent , Inconspicuous Dysplasia and Early-Stage Neoplasia in Barrett ' s Esophagus (2013) (0)
- Abstract 4321: Clinical-grade early detection of esophageal cancer on data from a non-endoscopic device using deep learning (2023) (0)
- Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications (2023) (0)
- Comprar Pre-Invasive Disease: Pathogenesis and Clinical Management | Fitzgerald, Rebecca C. | 9781441966933 | Springer (2011) (0)
- OC-060 A clinically applicable three gene signature is independently highly prognostic in oesophageal and junctional adenocarcinoma (2010) (0)
- Faculty Opinions recommendation of Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. (2013) (0)
- Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 (2019) (0)
- 1142: REAL-WORLD IMPLEMENTATION OF THE CYTOSPONGE TEST IN SECONDARY CARE FOR PATIENTS AT RISK OF EARLY OESOPHAGEAL CANCER (2022) (0)
- Barrett's oesophagus: diagnosis, surveillance and treatment. (2013) (0)
- Molecular Imaging via Novel Application of Fluorescent Lectins Permits Rapid Endoscopic Identification of Dysplasia in Barrett's Esophagus (2011) (0)
- Do Transcription Factors Hold the Key to Understanding the Development of Barrett’s Esophagus? (2012) (0)
- OWE-036 Implementation of cytospongetm device training for nurses in primary care (2018) (0)
- 464 MULTI-OMIC CHARACTERIZATION OF BARRETT'S ESOPHAGUS REVEALS A MOLECULAR CONTINUUM IN THE PROGRESSION TO ESOPHAGEAL ADENOCARCINOMA (2020) (0)
- Surveillance and Endoscopic Recognition of Gastric Intestinal Metaplasia and Atrophic Gastritis: A Retrospective Cohort Study in Two Academic Centers (2021) (0)
- Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus. (2020) (0)
- OC-003 Feasibility and performance characteristics of a novel disposable transnasal capsule device for barrett’s oesophagusscreening: an international multicentre trial (2017) (0)
- OC-066 The Cancer Research UK (Cruk) Funded ICGC Oesophageal Adenocarcinoma Project: MRC Research Centre and Cruk Cambridge Research Institute (2013) (0)
- PTH-167 Clinico-pathological characteristics of patients under barrett’s surveillance at a tertiary referral centre (2015) (0)
- PTU-019 Nasal or standard endoscopy (nose) for diagnosis of Barrett's oesophagus – efficacy and patient tolerance (2010) (0)
- OC-017 Autofluorescence-targeted Optical Biopsy Accurately Diagnoses Dysplasia In Barrett’s Oesophagus And Can Detect The Field Of Molecular Change (2014) (0)
- Oral Free Paper Sessions (2005) (0)
- PTH-184 Superior patient preference and high diagnostic accuracy for the detection of barrett’s oesophagus using a novel, portable, probe-based transnasal endoscope (2015) (0)
- OC-016 The Toll-like Receptor Pathway Is Recurrently Mutated In Oesophageal Adenocarcinoma (2014) (0)
- PTU-172 C-Myc as a Biomarker in Barrett’S Oesophagus (2013) (0)
- Novel prognostic targets identified using integrated analysis of copy number and expression data in oesophageal adenocarcinoma (2011) (0)
- oesophagus high grade dysplasia and cancer in Barrett ’ s Elastic scattering spectroscopy accurately detects (2006) (0)
- OC-040 First in-vivo study on the use of lectin-based molecular imaging in barrett’s oesophagus (2015) (0)
- PWE-171 Mobile element insertions are frequent and potentially mutagenic events in oesophageal carcinogenesis (2015) (0)
- PTU-173 Gord Symptoms and Demographic Factors as a Pre-Screening tool for Barrett’S Oesophagus (2013) (0)
- PTU-156 The Combination of Autofluorescence Imaging and Probe-Based Confocal Laser Endomicroscopy has an Excellent Diagnostic Accuracy for Dysplasia in Barrett’S Esophagus (2013) (0)
- PWE-108 Staining and dysplasia status in barrett’s oesophagus; a retrospective study (2017) (0)
- PWE-010 Dietary campesterol is inversely associated with the risk of developing oesophageal adenocarcinoma: a UK prospective study in the EPIC-Norfolk cohort, using information from 7-day food diaries (2012) (0)
- PTU-218 Pilot randomised cross-over study comparing the efficacy of transnasal Endosheath® to standard endoscopy to detect Barrett's oesophagus (2012) (0)
- PTU-128 Novel insights into metastatic spread of oesophageal adenocarcinoma from whole genome sequencing data (2015) (0)
- Why submit an abstract to UEG Week? (2015) (0)
This paper list is powered by the following services:
Other Resources About Rebecca Fitzgerald
What Schools Are Affiliated With Rebecca Fitzgerald?
Rebecca Fitzgerald is affiliated with the following schools:
